HomeCONGRESSInternational Congresses

International Congresses

View Category
Coronary Disease

TCT 2025 | INVEST-CTO: Effectiveness and Safety of a Planned Investment Procedure in High-Risk CTO PCI

The success rate of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains lower than for...
Dr. Andrés Rodríguez -
Learn More
Coronary Disease

TCT 2025 | INFINITY–SWEDEHEART: Long-Term Outcomes of the Bioadaptive Coronary Implant Versus Drug-Eluting Stent

The bioadaptive coronary implant DynamX (Elixir Medical, California) was developed to restore normal vascular function after angioplasty,...
Dr. Juan Manuel Pérez -
Learn More
Structural Heart Disease

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

The prospective, multicenter SUMMIT-MAC study evaluated the safety and efficacy of transcatheter mitral valve replacement (TMVR) using...
Dr. Juan Manuel Pérez -
Learn More
Bifurcations

TCT 2025 | OCVC-BIF Study: Use of Drug-Coated Balloon in Side Branches of Coronary Bifurcation Lesions

The randomized, multicenter, open-label OCVC-BIF trial was conducted across eight hospitals in the Osaka region (Japan) and...
Dr. Juan Manuel Pérez -
Learn More
Coronary Disease

TCT 2025 | REC-CAGEFREE I: Three-Year Follow-Up of Drug-Coated Balloon Angioplasty vs Stent in De Novo Coronary Lesions

The REC-CAGEFREE I trial evaluated the safety and efficacy of paclitaxel-coated balloon (DCB) angioplasty versus sirolimus-eluting stent...
Dr. Juan Manuel Pérez -
Learn More
Coronary Disease

TCT 2025 | IRONMAN II Study: Sirolimus-Eluting Iron Bioresorbable Stent in Coronary Artery Disease

Bioresorbable coronary stents represent a step toward strategies without permanent metallic implants, although the first polymer-based platforms...
Dr. Juan Manuel Pérez -
Learn More
Structural heart disease

TCT 2025 | PREVUE-VALVE: Prevalence of Valvular Heart Disease in Elderly US Patients

The PREVUE-VALVE study was designed to determine the true prevalence and demographic determinants of valvular heart disease...
Dr. Juan Manuel Pérez -
Learn More
Mitral valve

TCT 2025 | Transcatheter Mitral Valve Replacement with SAPIEN M3: ENCIRCLE 1-Year Outcomes

Transcatheter mitral valve replacement (TMVR) is an emerging option for patients with symptomatic mitral regurgitation (MR) who...
Dr. Juan Manuel Pérez -
Learn More